SCHEMBL3729581

SCHEMBL3729581

[CH2]C(C)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.57
LMNA P02545 2/20 0.57
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
HPGD P15428 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ACHE P22303 1/20 0.53
ACP3 P15309 1/20 0.51
MAPT P10636 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 4/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALOX15 P16050 1/20 0.48
HSP90AA1 P07900 1/20 0.47
HTT P42858 2/20 0.47
GAA P10253 1/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27594560 1.00 TSHR (0.57) TSHRLMNAKMT2AMEN1HPGD
Ethylene SCHEMBL27610334 0.85 TSHR (0.57) TSHRLMNAKMT2AMEN1HPGD
SCHEMBL254876 0.85 TSHR (0.61) TSHRLMNAKMT2AMEN1HPGD
SCHEMBL8062516 0.85 TSHR (0.61) TSHRLMNAKMT2AMEN1HPGD
SCHEMBL9026172 0.83 TSHR (0.59) TSHRLMNAKMT2AMEN1HPGD
SCHEMBL10654030 0.81 TSHR (0.57) TSHRLMNAKMT2AMEN1HPGD
SCHEMBL6359586 0.81 TSHR (0.57) TSHRLMNAKMT2AMEN1HPGD
SCHEMBL2540712 0.81 TSHR (0.57) TSHRLMNAKMT2AMEN1HPGD
SCHEMBL3474640 0.81 MEN1 (0.61) TSHRLMNAKMT2AMEN1HPGD
SCHEMBL3858019 0.81 TSHR (0.57) TSHRLMNAKMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9955689-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-01 US disclosed
US-9894901-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-20 US disclosed
US-9872493-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-23 US disclosed
US-20150305332-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-29 US disclosed
US-20150289506-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-15 US disclosed
US-20150289512-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-15 US disclosed
US-20150282482-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-08 US disclosed
EP-2926660-A1 METHOD FOR PROMOTING PLANT GROWTH Sumitomo Chemical Company Limited (JP) 2015-10-07 EP disclosed
EP-2923574-A1 METHOD FOR PROMOTING PLANT GROWTH Sumitomo Chemical Company Limited (JP) 2015-09-30 EP disclosed
EP-2923573-A1 METHOD FOR PROMOTING PLANT GROWTH Sumitomo Chemical Company Limited (JP) 2015-09-30 EP disclosed
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
US-20130225540-A1 SUPPRESSION OF GLIAL FIBRILLARY ACIDIC PROTEIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-08-29 US disclosed
US-8372808-B2 Suppression of glial fibrillary acidic protein WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-02-12 US disclosed
US-20100190705-A1 Suppression of glial fibrillary acidic protein WISCONSIN ALUMNI RESEARCH FOUNDATION 2010-07-29 US disclosed
CN-1217936-C Heterocyclic compounds having sulfonic acid EISAI CO LTD (JP) 2005-09-07 CN disclosed
CN-1414952-A Heterocyclic compounds having sulfonic acid EISAI CO LTD (JP) 2003-04-30 CN disclosed
US-3936462-A CNS DEPRESSANT, ANALGESIC STERLING DRUG INC. (US) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190705-A1 Suppression of glial fibrillary acidic protein NEFM, CLN6, GMFG TSHR 4478/4885LMNA 129/4885KMT2A 2826/4885
US-20150289506-A1 METHOD FOR PROMOTING PLANT GROWTH FGF2, BROX, BOLA2; BOLA2B TSHR 1280/4885LMNA 4787/4885KMT2A 1223/4885
US-20150305332-A1 METHOD FOR PROMOTING PLANT GROWTH FGF1, BROX, FGF2 TSHR 1528/4885LMNA 4306/4885KMT2A 1800/4885
US-20150282482-A1 METHOD FOR PROMOTING PLANT GROWTH BOLA2; BOLA2B, BROX, TET1 TSHR 1132/4885LMNA 4736/4885KMT2A 407/4885
US-20150289512-A1 METHOD FOR PROMOTING PLANT GROWTH FGF1, MKI67, FGF2 TSHR 3362/4885LMNA 4248/4885KMT2A 2323/4885
US-20130225540-A1 SUPPRESSION OF GLIAL FIBRILLARY ACIDIC PROTEIN NEFM, CLN6, GMFG TSHR 4478/4885LMNA 129/4885KMT2A 2826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.